Early Effects of the ESRD Treatment Choices Model on Kidney Transplant Waitlist Additions
Clin J Am Soc Nephrol
.
2024 Oct 16.
doi: 10.2215/CJN.0000000000000571.
Online ahead of print.
Authors
Vishnu S Potluri
1
2
,
Yuvaram N V Reddy
1
2
3
,
Sri Lekha Tummalapalli
4
5
,
Chen Peng
6
,
Qian Huang
6
,
Yueming Zhao
6
,
Genevieve P Kanter
7
,
Jingsan Zhu
6
,
Joshua M Liao
2
8
,
Amol S Navathe
2
3
6
Affiliations
1
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
2
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
3
Center for Health Equity Research and Promotion, Corporal Crescenz VA Medical Center, Philadelphia, Pennsylvania.
4
Division of Healthcare Delivery Science and Innovation, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
5
Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
6
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
7
Sol Price School of Public Policy, University of Southern California, Los Angeles, California.
8
Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
PMID:
39475825
DOI:
10.2215/CJN.0000000000000571
No abstract available
Grants and funding
Pilot Grant/Leonard Davis Institute for Health Economics
K08 DK127250/DK/NIDDK NIH HHS/United States
K08HS028684/Agency for Healthcare Research and Quality
R01 MD013859-01/MD/NIMHD NIH HHS/United States
K08 HS028684/HS/AHRQ HHS/United States
R01 HS027595-01A1/Agency for Healthcare Research and Quality
K12HS026372/Agency for Healthcare Research and Quality
HHSH250-2019-00001C/HRSA/HRSA HHS/United States